Citadel Advisors
CVRX icon

Citadel Advisors’s CVRx CVRX Stock Holding History

Citadel Advisors’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
+15,800
New +$116K ﹤0.01% 11685
2025
Q4 		– Sell
-30,300
Closed -$245K – 12854
2025
Q3 		$245K Sell
30,300
-2,100
-6% -$15.8K ﹤0.01% 10808
2025
Q2 		$191K Buy
32,400
+12,400
+62% +$85.5K ﹤0.01% 10719
2025
Q1 		$245K Buy
20,000
+13,700
+217% +$193K ﹤0.01% 10038
2024
Q4 		$79.8K Sell
6,300
-20,600
-77% -$254K ﹤0.01% 11788
2024
Q3 		$237K Buy
26,900
+24,800
+1,181% +$226K ﹤0.01% 9802
2024
Q2 		$25.2K Sell
2,100
-11,800
-85% -$136K ﹤0.01% 12431
2024
Q1 		$253K Buy
13,900
+3,500
+34% +$82.9K ﹤0.01% 9837
2023
Q4 		$327K Sell
10,400
-24,700
-70% -$463K ﹤0.01% 9001
2023
Q3 		$532K Buy
35,100
+24,800
+241% +$408K ﹤0.01% 7927
2023
Q2 		$159K Sell
10,300
-6,200
-38% -$75.7K ﹤0.01% 10245
2023
Q1 		$154K Buy
16,500
+13,800
+511% +$183K ﹤0.01% 10599
2022
Q4 		$49.5K Buy
+2,700
New +$33.3K ﹤0.01% 12149
2022
Q3 		– Sell
-10,100
Closed -$61K – 12765
2022
Q2 		$61K Buy
+10,100
New +$58.1K ﹤0.01% 11805

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's CVRX Position: Q1 2026 in Review

Citadel Advisors reduced its CVRx (CVRX) stake by 91% in Q1 2026, selling an estimated $2.04M and leaving 26,627 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #10894.

Citadel Advisors first reported a position in CVRX in Q2 2021 and has held it in 14 quarters since. The position peaked at $3.12M in Q1 2025. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Citadel Advisors held 26,627 shares of CVRx worth $252K as of Q1 2026.
  • Citadel Advisors sold 278,876 CVRx shares in Q1 2026, an estimated $2.04M.
  • CVRx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10894 holding.
  • Citadel Advisors first reported a position in CVRx in Q2 2021 and has held it in 14 quarters since.
  • Citadel Advisors's CVRx position peaked at $3.12M in Q1 2025.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.